Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-15 Purchase |
2022-03-16 08:35 am |
PLx Pharma Inc. | PLXP | Giordano Natasha Chief Executive Officer |
4,100 | $3.6529 | $14,977 | 5,186 (Direct) |
View |
| 2022-03-15 Purchase |
2022-03-16 08:33 am |
PLx Pharma Inc. | PLXP | O'Connor Rita M Chief Financial Officer |
13,700 | $3.6585 | $50,122 | 26,670 (Direct) |
View |
| 2021-06-14 Purchase |
2021-06-15 4:47 pm |
PLx Pharma Inc. | PLXP | Valentino Michael J Executive Chairman |
8,000 | $12.48 | $99,870 | 494,690 (Direct) |
View |
| 2021-03-05 Purchase |
2021-03-09 5:06 pm |
PLx Pharma Inc. | PLXP | Valentino Michael J Executive Chairman |
25,000 | $8 | $200,000 | 486,690 (Direct) |
View |
| 2020-12-14 Purchase |
2020-12-15 5:38 pm |
PLx Pharma Inc. | PLXP | HADDEN JOHN Director |
1,000 | $5.448 | $5,448 | 3,690 (Direct) |
View |
| 2020-11-25 Purchase |
2020-11-25 4:08 pm |
PLx Pharma Inc. | PLXP | HADDEN JOHN Director |
500 | $5.4757 | $2,738 | 2,690 (Direct) |
View |
| 2020-11-18 Purchase |
2020-11-20 7:46 pm |
PLx Pharma Inc. | PLXP | Valentino Michael J Executive Chairman |
264,900 | $3.787 | $1,003,176 | 913,080 (Direct) |
View |
| 2020-09-01 Purchase |
2020-09-03 08:49 am |
PLx Pharma Inc. | PLXP | O'Connor Rita M Chief Financial Officer |
6,620 | $3.771 | $24,964 | 12,970 (Direct) |
View |
| 2020-08-20 Purchase |
2020-08-24 09:12 am |
PLx Pharma Inc. | PLXP | O'Connor Rita M Chief Financial Officer |
6,350 | $3.8986 | $24,756 | 6,350 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-22 Option Award |
2022-02-24 8:18 pm |
N/A 2032-02-22 |
PLx Pharma Inc. | PLXP | Valentino Michael J Executive Chairman |
80,000 | $0 | 80,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 8:16 pm |
N/A 2032-02-22 |
PLx Pharma Inc. | PLXP | O'Connor Rita M Chief Financial Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 8:14 pm |
N/A 2032-02-22 |
PLx Pharma Inc. | PLXP | HADDEN JOHN Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 8:13 pm |
N/A 2032-02-22 |
PLx Pharma Inc. | PLXP | Giordano Natasha Chief Executive Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 8:12 pm |
N/A 2032-02-22 |
PLx Pharma Inc. | PLXP | Casale Robert Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 8:11 pm |
N/A 2032-02-22 |
PLx Pharma Inc. | PLXP | CALHOUN KIRK K Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 8:10 pm |
N/A 2032-02-22 |
PLx Pharma Inc. | PLXP | Balkema Gary S. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-11 09:02 am |
N/A 2031-08-09 |
PLx Pharma Inc. | PLXP | O'Connor Rita M Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-11 09:01 am |
N/A 2031-08-09 |
PLx Pharma Inc. | PLXP | Giordano Natasha Chief Executive Officer |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2021-03-16 3:44 pm |
N/A N/A |
PLx Pharma Inc. | PLXP | Level One Partners LLC Hardie Robert D. Hardie Molly G. 10% Owner |
0 | $0 | 3,647,643 (Direct) |
View |
| 2020-11-18 Option Award |
2020-11-20 7:46 pm |
N/A 2030-11-18 |
PLx Pharma Inc. | PLXP | Valentino Michael J Executive Chairman |
160,000 | $0 | 913,080 (Direct) |
View |
| 2020-11-18 Option Award |
2020-11-20 7:43 pm |
N/A 2030-11-18 |
PLx Pharma Inc. | PLXP | O'Connor Rita M Chief Financial Officer |
174,000 | $0 | 174,000 (Direct) |
View |
| 2020-11-18 Option Award |
2020-11-20 7:41 pm |
N/A 2030-11-18 |
PLx Pharma Inc. | PLXP | HADDEN JOHN Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2020-11-18 Option Award |
2020-11-20 7:39 pm |
N/A 2030-11-18 |
PLx Pharma Inc. | PLXP | Giordano Natasha Chief Executive Officer |
350,000 | $0 | 350,000 (Direct) |
View |
| 2020-11-18 Option Award |
2020-11-20 7:36 pm |
N/A 2030-11-18 |
PLx Pharma Inc. | PLXP | Casale Robert Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2020-11-18 Option Award |
2020-11-20 7:32 pm |
N/A 2030-11-18 |
PLx Pharma Inc. | PLXP | CALHOUN KIRK K Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2020-11-18 Option Award |
2020-11-20 7:30 pm |
N/A 2030-11-18 |
PLx Pharma Inc. | PLXP | Balkema Gary S. Director |
40,000 | $0 | 40,000 (Direct) |
View |